JD

Joris De Maeyer

Executive in Biotech & VC Industry

Mechelen, Flemish Region

Invests in

Stages:

Sectors:

Pharmaceuticals

Consumer Health

Health & Hospital Services

Locations:

Antwerp, Belgium

Min Investment:
$100,000.00
Max Investment:
$5,000,000.00
Target Investment:
$1,500,000.00

Skills

Project Management

Research Funding

Drug Development

Gastroenterology

Pharmacodynamics

Pharmaceutical Industry

Translational Research

Pharmacokinetics

Research and Development (R&D)

Education

PhD
Ghent University
(2002 - 2008)
Master's degree
KU Leuven
(1994 - 2000)
Vrije Universiteit Brussel

Work Experience

Bioqube Ventures

2016

Executive in Residence
2023
Investment Director
2020 - 2023
Venture Coach
2016 - 2020

Anavo Therapeutics BV

2021

Board Observer
2021

Stealth Mode NewCo

2023

Founder
2023

LIFE of SCI

2013

Managing Director - Life Science Consulting
2013

Facio Therapies

2014 - 2022

Chief Executive Officer
2021 - 2022
Acting Chief Executive Officer
2021 - 2021
Chief Scientific Officer
2019 - 2021
Director R&D
2014 - 2019

2011 - 2013

Director Discovery
2011 - 2013

2007 - 2010

Manager Drug Discovery
2007 - 2010

Johnson & Johnson

2001 - 2006

Research Associate Drug Discovery
2002 - 2006
Senior Associate Quality Assurance Preclinical Research & Development (PKPD TOX)
2001 - 2002

Vlaamse Milieumaatschappij - VMM

2001 - 2001

Auditor Surface Water Monitoring Network
2001 - 2001
Temporary assignment.

2000 - 2001

Research associate
2000 - 2001